SAN ANTONIO (EGMN) - A novel test for prediction of an individual's breast cancer risk that incorporates gene-based information along with clinical and lifestyle data significantly outperformed the widely used Gail model in a validation study.The test, known as OncoVue, utilises data from a patient questionnaire along with DNA from buccal cells obtained by a mouthwash rinse. The cells are genotyped for 22 single nucleotide polymorphisms (SNPs) located on 19 genes believed to influence breast carcinogenesis....